Cortical Labs
+8%
est. 2Y upside i
Cortical Labs is a biological computing company at the heart of a new era with the world’s first commercial biological computer, the CL1 – available for independent lab use and remote cloud connection.
Rank
#1879
Sector
Biological Computing
Est. Liquidity
~5Y
Data Quality
Data: LowCortical Labs offers high-risk, high-reward equity.
Last updated: July 19, 2026
Cortical Labs achieves commercial breakthrough with data center and biopharma contracts, driving revenue to $5M by 2028. Exit multiple expands to 30x revenue, yielding 80% net upside after 20% dilution.
Revenue grows to $2M with steady adoption from research labs. Exit multiple of 20x yields 30% net upside after 20% dilution.
Regulatory or ethical hurdles slow adoption; revenue remains below $1M. Exit multiple contracts to 10x, valuation falls below $12M, leaving common stock worth -100% after preference liquidation.
Preference Stack Risk
highFunding Intensity
2320%Total funding of $11.6M represents 23.2% of estimated $50M valuation, creating a high preference overhang.
Dilution Risk
highAs a Series A without disclosed revenue, the company will likely raise additional rounds, diluting current equity by ~20% over 2 years.
Secondary Liquidity
noneNo secondary market exists; liquidity only upon acquisition or IPO.
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Cortical Labs's data — designed to show you've done your homework.
- 1
“How does Cortical Labs plan to address ethical concerns regarding consciousness in organoid brains?”
- 2
“What is the unit economics of the CL1 and Cortical Cloud?”
- 3
“What is the expected timeline to liquidity for early employees given the early stage?”
Community
Valuation Sentiment
Our model estimates +8% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.